Skip to content
sellWeak

Emil Kuriakose sold $26k of TERN

Chief Medical Officer at Terns Pharmaceuticals, Inc.. 4,481 shares at an average of $5.71, traded Jan 2, 2025, filed Jan 6, 2025.

Warning score
20
Value
$26k
4,481 shares
Holdings after
54,269
-8% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $26k at market
    +5
  • Share of holdings sold
    Sold 7.6% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Rows in this filing

Every transaction in Form 4 0001562180-25-000221, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jan 2, 2025SOpen-market sale
Common Stock
-4,481$5.71$26k54,269Jan 6, 2025

Related signals

Other insiders at Terns Pharmaceuticals, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
44Moderate
TERNbuy
Terns Pharmaceuticals, Inc.
Amy L. Burroughs
Chief Executive Officer
$90k
23,314 shares
+98%
33Weak
TERNbuy 2
Terns Pharmaceuticals, Inc.
Amy L. Burroughs
Chief Executive Officer
$2,606
510 shares
+3%
31Weak
TERNbuy 2
Terns Pharmaceuticals, Inc.
Melita Sun Jung
Chief Business Officer
$11k
2,250 shares
-
58Moderate
TERNbuy 2
Terns Pharmaceuticals, Inc.
Amy L. Burroughs
Chief Executive Officer
$110k
15,450 shares
+423%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Emil Kuriakose sold $26k of TERN | InsiderTell